Close
Smartlab Europe
Inizio Ignite

Press Releases

Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that it has entered into an additional agreement with Lonza to support drug substance manufacturing for its global supply chain. The agreement will establish a new...

World Health Organization Authorizes SINOVACs CoronaVac for Emergency Use

SINOVAC Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that CoronaVac®, an innovative, inactivated coronavirus vaccine developed by SINOVAC Life Sciences Co., Ltd., a subsidiary of the Company, was approved for emergency use under the World...

Greenphire Announces Strategic Growth Investment from Thoma Bravo

Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, announced that it has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The...

Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb

Exscientia, the clinical stage, Artificial Intelligence (AI)-driven pharmatech company, announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company. This expanded collaboration has the potential to add to the Bristol Myers Squibb drug pipeline whilst enhancing...

LATAM Cargo Group collaborates with SkyCell to bring hybrid to South America’s pharma market

Fulfilling our mission to deliver medicine to all means shipping pharma products to remote and infrastructurally challenging environments across the world. With our hybrid containers engineered and designed to safeguard cargo in the most extreme conditions, our solution is...

MedPharm Announces Expansion of Formulation Development and Analytical Service Labs in the UK

MedPharm Ltd, the world leader in formulation development and analytical services for topical and transdermal products, is thrilled to announce a £1.5M investment into the refurbishment and expansion of our 15,000 sq ft campus in Surrey, UK that will increase our UK laboratory...

Roche’s Antibody Cocktail is now available in India, Cipla to market it pan-India

Roche India and Cipla Limited announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India while a second batch will be made available by mid-June. In total they can potentially benefit 200,000...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »